These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30332922)

  • 1. Finding the structural requirements of diverse HIV-1 protease inhibitors using multiple QSAR modelling for lead identification.
    Halder AK
    SAR QSAR Environ Res; 2018 Nov; 29(11):911-933. PubMed ID: 30332922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyethylamine derivatives as HIV-1 protease inhibitors: a predictive QSAR modelling study based on Monte Carlo optimization.
    Bhargava S; Adhikari N; Amin SA; Das K; Gayen S; Jha T
    SAR QSAR Environ Res; 2017 Dec; 28(12):973-990. PubMed ID: 29072112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating Multiple Receptor Conformation Docking and Multi Dimensional QSAR for Enhancing Accuracy of Binding Affinity Prediction.
    Radhika V; Jaraf HA; Kanth SS; Vijjulatha M
    Curr Comput Aided Drug Des; 2017; 13(2):127-142. PubMed ID: 28103770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations.
    Toropov AA; Toropova AP; Benfenati E; Leszczynska D; Leszczynski J
    J Comput Chem; 2010 Jan; 31(2):381-92. PubMed ID: 19479738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR studies on HIV-1 protease inhibitors using non-linearly transformed descriptors.
    Saranya N; Selvaraj S
    Curr Comput Aided Drug Des; 2012 Mar; 8(1):10-49. PubMed ID: 21999608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fragment-Based QSAR and Structural Analysis of a Series of Hydroxyethylamine Derivatives as HIV-1 Protease Inhibitors.
    Ferreira LG; Andricopulo AD
    Comb Chem High Throughput Screen; 2015; 18(5):464-75. PubMed ID: 25961662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based QSAR analysis of a set of 4-hydroxy-5,6-dihydropyrones as inhibitors of HIV-1 protease: an application of the receptor-dependent (RD) 4D-QSAR formalism.
    Santos-Filho OA; Hopfinger AJ
    J Chem Inf Model; 2006; 46(1):345-54. PubMed ID: 16426069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors.
    Fatemi MH; Heidari A; Gharaghani S
    J Theor Biol; 2015 Mar; 369():13-22. PubMed ID: 25600056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative molecular field analysis (CoMFA), topomer CoMFA, and hologram QSAR studies on a series of novel HIV-1 protease inhibitors.
    Heidari A; Fatemi MH
    Chem Biol Drug Des; 2017 Jun; 89(6):918-931. PubMed ID: 27933723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of conceptual DFT descriptors and docking scores on the QSAR models of HIV protease inhibitors.
    Srivastava HK; Choudhury C; Sastry GN
    Med Chem; 2012 Sep; 8(5):811-25. PubMed ID: 22741804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring QSARs for inhibitory activity of non-peptide HIV-1 protease inhibitors by GA-PLS and GA-SVM.
    Deeb O; Goodarzi M
    Chem Biol Drug Des; 2010 May; 75(5):506-14. PubMed ID: 20486937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validated predictive QSAR modeling of N-aryl-oxazolidinone-5-carboxamides for anti-HIV protease activity.
    Halder AK; Jha T
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6082-7. PubMed ID: 20832304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of anti-HIV activity models of lysine sulfonamide analogs: a QSAR perspective.
    Muthukumaran R; Sangeetha B; Amutha R; Mathur PP
    Curr Comput Aided Drug Des; 2012 Mar; 8(1):70-82. PubMed ID: 21999609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 protease inhibitors: a comparative QSAR analysis.
    Kurup A; Mekapati SB; Garg R; Hansch C
    Curr Med Chem; 2003 Sep; 10(17):1679-88. PubMed ID: 12871116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-independent 4D-QSAR analysis of a set of norstatine derived inhibitors of HIV-1 protease.
    Senese CL; Hopfinger AJ
    J Chem Inf Comput Sci; 2003; 43(4):1297-307. PubMed ID: 12870923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. InChI-based optimal descriptors: QSAR analysis of fullerene[C60]-based HIV-1 PR inhibitors by correlation balance.
    Toropov AA; Toropova AP; Benfenati E; Leszczynska D; Leszczynski J
    Eur J Med Chem; 2010 Apr; 45(4):1387-94. PubMed ID: 20116899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational studies on HIV-1 protease inhibitors: influence of calculated inhibitor-enzyme binding affinities on the statistical quality of 3D-QSAR CoMFA models.
    Jayatilleke PR; Nair AC; Zauhar R; Welsh WJ
    J Med Chem; 2000 Nov; 43(23):4446-51. PubMed ID: 11087569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards designing of a potential new HIV-1 protease inhibitor using QSAR study in combination with Molecular docking and Molecular dynamics simulations.
    Baassi M; Moussaoui M; Soufi H; Rajkhowa S; Sharma A; Sinha S; Belaaouad S
    PLoS One; 2023; 18(4):e0284539. PubMed ID: 37079533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype dependent QSAR for HIV-1 protease inhibition.
    Boutton CW; De Bondt HL; De Jonge MR
    J Med Chem; 2005 Mar; 48(6):2115-20. PubMed ID: 15771454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of radial distribution function-based descriptors in the chemoinformatic studies of HIV-1 protease.
    Novak J; Grishina MA; Potemkin VA; Gasteiger J
    Future Med Chem; 2020 Feb; 12(4):299-309. PubMed ID: 31983244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.